Alveo Wins XPRIZE Rapid Covid-19 Testing Competition. Click
here to read the news.
May 1, 2019
We are pleased to announce that famed American Geneticist George Church will be joining Alveo’s Scientific Advisory Board. With extensive background in medical diagnostics, including founding application-based companies, George will bring valuable expertise to our...
May 1, 2019
It is my pleasure to announce today, May 1, 2019, that John P. DeVincenzo, M.D. is joining our Scientific Advisory Board. With more than twenty years of pathogenetic and virus research within the healthcare sector, John brings deep experience in pediatric infectious...
Jul 12, 2018
SAN FRANCISCO – July 12, 2018 – Alveo Technologies, Inc., (“Alveo” or “the Company”) a medical diagnostics firm whose mission is to create affordable and accessible infectious disease diagnostics, announced today the appointments of two...
Jan 5, 2018
SAN FRANCISCO – Jan 5, 2018 – Alveo Technologies, Inc., (“Alveo” or “the Company”) whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised...
